Adhera Therapeutics (ATRX)
OTHER OTC:ATRX
US Market
Holding ATRX?
Track your performance easily

Adhera Therapeutics (ATRX) Financial Statements

12 Followers

Adhera Therapeutics Financial Overview

Adhera Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.249; its P/E ratio is >-0.01; Adhera Therapeutics is scheduled to report earnings on May 18, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue--$ -347.00K-$ 0.00
Gross Profit--$ -347.00K--
EBIT$ -2.93M$ 628.00K$ -199.00K$ -879.00K$ -710.00K
EBITDA$ -2.93M-$ 409.00K$ -335.00K$ -710.00K
Net Income Common Stockholders$ -3.56M$ 245.00K$ -206.00K$ -177.00K$ -1.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.39K$ 58.00K$ 69.00K$ 32.00K$ 133.00K
Total Assets$ 44.07K$ 82.00K$ 104.00K$ 79.00K$ 256.00K
Total Debt$ 10.83M$ 10.59M$ 9.63M$ 8.59M$ 7.99M
Net Debt$ 10.80M$ 10.53M$ 9.56M$ 8.55M$ 7.86M
Total Liabilities$ 26.36M$ 22.87M$ 23.20M$ 22.27M$ 22.06M
Stockholders Equity$ -26.32M$ -22.79M$ -23.09M$ -22.19M$ -21.81M
Cash Flow-
Free Cash Flow$ -29.16K-$ -310.00K$ -115.00K$ -572.00K
Operating Cash Flow$ -29.16K$ -316.00K$ -310.00K$ -115.00K$ -572.00K
Investing Cash Flow-----
Financing Cash Flow$ 3.78K$ 305.00K$ 347.00K$ 52.00K$ -144.00K
Currency in USD

Adhera Therapeutics Earnings and Revenue History

Adhera Therapeutics Debt to Assets

Adhera Therapeutics Cash Flow

Adhera Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis